Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
==================================================================================================================================

* Jieqiong Liu
* Qiang Liu
* Ying Li
* Qian Li
* Fengxi Su
* Herui Yao
* Shicheng Su
* Quanren Wang
* Liang Jin
* Ying Wang
* Wan Yee Lau
* Zefei Jiang
* Erwei Song